Chemistry: natural resins or derivatives; peptides or proteins; – Proteins – i.e. – more than 100 amino acid residues – Nucleoproteins – e.g. – chromatin – chromosomal proteins,...
Patent
1997-09-23
1999-11-02
Hutzell, Paula K.
Chemistry: natural resins or derivatives; peptides or proteins;
Proteins, i.e., more than 100 amino acid residues
Nucleoproteins, e.g., chromatin, chromosomal proteins,...
530350, 514 2, 514 21, A61K 3816, C07K 100, A01N 3718
Patent
active
059773111
ABSTRACT:
The present invention relates to complexes of the 53BP2 protein with proteins identified as interacting with 53BP2 by a yeast two hybrid assay system. The proteins identified to interact with 53BP2 are .beta.-tubulin, p62, hnRNP G, and three gene products, 53BP2-IP1, 53BP2-IP2, and 53BP2-IP3 encoded, in part, by the EST R72810 sequence. Thus, the invention provides complexes of 53BP2 and .beta.-tubulin, p62, hnRNP G, 53BP2-IP1, 53BP2-IP2, and 53BP2-IP3 and derivatives, fragments and analogs thereof. The invention also provides the 53BP2-IP1, 53BP2-IP2 and 53BP2-IP3 genes and proteins and derivatives, fragments and analogs thereof. Methods of screening the complexes for efficacy in treating and/or preventing certain diseases and disorders, particularly cancer, autoimmune disease and neurodegenerative disease are also provided.
REFERENCES:
Burgess et al., Possible Dissociation of the Heparin-binding and Mitogenic Activities of Heaprin-binding (Acidic Fibroblast) Growth Factor-1 from Its Receptor-binding Activities by Site-directed Mutagenesis of a Single Lysine Residue, J of Cell Bio. 111:2, 1990.
Lazar et al., Transforming Growth Factor alpha: Mutation of Aspartic Acid 47 and Leucine 48 Results in Different Biological Activities, Molecular and Cellular Biology 8:1247-1252, Mar. 1988.
Tao et al., Studies of Aglycolsylated Chimeric Mouse-Human IgG, The Journal of Immunology, 143:2595-2601, 1989.
Bowie et al, Deciphering the Message in Protein Sequences: Tolerance to Amino Acid Substitutions, Science 247:1306-1310, Mar. 1990.
Naumovski et al, The p53-Binding Protein 53BP2 Also Interacts with Bcl2 and Impedes Cell Cycle Progression at G2/M, Molecular and Cell Biology 16(7):3884-3892, Jul. 11, 1996.
Wilson et al, 2.2 Mb of contiguous nucleotide sequence from chromosome III of C. elegans, Nature 368(6466): 32-38, Mar. 3, 1994.
Herzog et al, Accession Q61869 in J. Inves. Dermatol 102:165-170, Mar. 10, 1994.
Banerjee, 1997. "Differential effects of colchicine and its B-ring modified analog MTPT on the assembly-independent GTPase activity of purified beta-tubulin isoforms from bovine brain." Biochem Biophys Res Commun. 231: 698-700.
Chien, et al., "The two-hybrid system: a method to identify and clone genes for proteins that interact with a protein of interest." Proc Natl Acad Sci USA. 88: 9578-9581, 1991.
Clark, et al., 1995. "Increased detection of specific tyrosine phosphoproteins correlates with tumor progression of Abelson virus-infected lymphocytes." Leukemia. 9: 165-174.
Farine. 1997. "Animal models in autoimmune disease in immunotoxicity assessment." Toxicol., 119: 29-35.
Goldspiel, et al. 1993. "Human gene therapy." Clinical Pharmacy, 12: 488-505.
Good, et al. 1997. "Expression of small, therapeutic RNAs in human cell nuclei." Gene Therapy, 4: 45-54.
Gorina, et al., 1996. "Structure of the p53 tumor suppressor bound to the ankyrin and SH3 domains of 53BP2." Science. 274: 1001-1005.
Grassi, et al. 1996. "Ribozymes: structure, function, and potential therapy for dominant genetic disorders." Annals of Med., 28: 499-510.
Hecker, et al., 1996. "Complex regulation of the DNA-binding activity of p53 by phosphorylation: differential effects of individual phosphorylation sites on the interaction with different binding motifs." Oncogene. 12: 953-961.
Helps, et al., 1995. "Protein phosphatase 1 interacts with p53BP2, a protein which binds to the tumour suppressor p53." FEBS Letts. 377:295-300.
Itoh, et al., 1996. "Beta-tubulin binds Src homology 2 domains through a region different from the tyrosine-phosphorylated protein-recognizing site." J Biol Chem. 217: 27931-27935.
Iwabuchi, et al., 1994. "Two cellular proteins that bind to wild-type but not mutant p53." Proc Natl Acad Sci USA. 91: 6098-6102.
Kunkel, et al., 1996. "The role of chemokines in inflammatory joint disease." J Leukocyte Biol. 59:6-12.
Martin, et al., "Stimulation of E2F1/DP1 transcriptional activity by MDM2 oncoprotein." Nature. 375: 691-694, 1995.
Milne, 1994. "Phosphorylation of the tumor suppressor protein p53 by mitogen-activated protein kinases." J Biol Chem. 269: 9253-9260.
Naumovski, et al., 1996. "The p53-binding protein 53BP2 also interacts with Bc12 and impedes cell cycle progression at G2/M." Mol Cell Biol. 16: 3884-3892.
Neet, et al., 1995. "The nonreceptor protein-tyrosine kinase CSK complexes directly with the GTPase-activating protein-associated p62 protein in cells expressing v-Src or activated c-Src." Mol Cell Biol. 15: 4908-4920.
Popovic, "Behavioral and adaptive status in an experimental model of Alzheimer's disease in rats." Int J Neurosci. 86: 281-299, 1996.
Ranganathan, et al., 1997. "Immunohistochemical analysis of beta-tubulin isotypes in human prostate carcinoma and benign prostatic hypertrophy." Prostate. 30:263-268.
Richard, et al., 1995. "Association of p62, a multifunctional Sh2- and Sh3-domain-binding protein, with src family tyrosine kinases, Grb2, and phospholipase C gamma-1." Mol Cell Biol. 15: 186-197.
Soulard, et al., 1993. "hnRNP G: sequence and characterization of a glycosylated RNA-binding protein." Nuc Acids Res. 21: 4210-4217.
Tucker, et al., 1997. "Probing the kinesin-microtubule interaction." J Biol Chem. 272: 9481-9488.
Vadlamudi, et al., 1996. "p62, a phosphotyrosine-independent ligand of the SH2 domain of p561ck, belongs to a new class of ubiquitin-binding proteins." J Biol Chem. 271: 20235-0237.
Wang, et al., 1995. "P62 association with RNA is regulated by tyrosine phosphorylation." J Biol Chem. 270: 2010-2013.
Wong, et al., 1992. "Molecular cloning and nucleic acid binding properties of the GAP-associated tyrosine phosphoprotein p62." Cell. 69: 551-558.
Nandabalan Krishnan
Schulz Vincent Peter
Yang Meijia
CuraGen Corporation
Elrifi Ivor R.
Hutzell Paula K.
Worrall Timothy A.
LandOfFree
53BP2 complexes does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 53BP2 complexes, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 53BP2 complexes will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2136924